Sulfobutylether Beta Cyclodextrin Sodium Salt CAS No. 182410-00-0

Sulfobutylether Beta Cyclodextrin Sodium Salt CAS No. 182410-00-0

Wholesale Sulfobutylether Beta Cyclodextrin Sodium Salt CAS No. 182410-00-0 made in China from DELI. Our factory is a famous Sulfobutylether Beta Cyclodextrin Sodium Salt CAS No. 182410-00-0 manufacturers and suppliers in China. We will provide free sample. Our products are in stock. Welcome to buy our bulk products.

Send Inquiry

Product Description

    Xi'an Deli Biochemical Industry Co.,Ltd. Is a high-tech enterprise specializing in research & development, production & sales of cyclodextrin and its derivatives. Since its establishment on August 27, 1999,the company has been adhering to the quality Policy of "focusing on accessories, quality first, sincere service, striving for first-class". After more than 20 years of hard work and development, the company currently has products DELI Brand Hydroxypropyl Betadex, DELI Brand Betadex Sulfobutyl Ether Sodium. The above products have been registered and filed with the FDA.

    Wholesale Sulfobutylether-β-Cyclodextrin sodium salt CAS 182410-00-0 made in China from DELI. Our factory is a famous Sulfobutylether-β-Cyclodextrin sodium salt CAS 182410-00-0 manufacturers and suppliers in China. We will provide free sample. Our products are in stock. Welcome to buy our bulk products.

   Sulfobutylether-β-Cyclodextrin sodium salt CAS 182410-00-0 has been used in injection, oral, nasal and eye medicines. It has a special affinity and inclusion for nitrogen drugs. Increase the drug's stability ,solubility ,safety (Include drug molecules to form non-covalent). Reduce renal toxicity, ease drug hemolysis. Sulfobutyl Ether Beta Cyclodextrin Sodium also can control the drug release rate, cover the bad smell.


Sulfobutylether Beta Cyclodextrin Sodium Salt CAS No. 182410-00-0

Product Overview


Sulfobutylether Beta Cyclodextrin Sodium Salt (SBECD) is a highly water-soluble, anionic β-cyclodextrin derivative developed as a pharmaceutical excipient for injectable drug delivery systems. By forming non-covalent inclusion complexes with active pharmaceutical ingredients (APIs), SBECD significantly improves solubility, stability, and formulation safety of poorly water-soluble drugs.

With excellent biocompatibility, low hemolytic potential, and controlled toxicity, SBECD is widely used in parenteral formulations for critical therapeutic areas including antiviral, antifungal, oncology, and cardiovascular medicines.


Description and Solubility/ see details in the USP Monograph

White to off-white,amorphous powder.Freely soluble in water;sparingly soluble in methanol;practically insoluble in ethanol,in n-hexane,in 1-butanol,in acetonitrile,in 2-propanol,and in ethylacetate

Identification A/IR; USP<197K>

Complies with SBECD reference

Identification B/(Assay method)HPLC;

USP<621>

tR of the major peak complies with SBECD  reference

Identification C/CE; USP<1053>

It meets the requirements of the test for Average Degree of Substitution.

Identification D/USP<191>

Positive test for sodium

Assay/HPLC;USP<621>

95.0%-105.0% on the anhydrous basis

Limit of Beta Cyclodextrin(Betadex)/IC;

USP<621>;USP<1065>

 NMT 0.1%

Limit of 1,4-Butane Sultone /GC;USP<621>,

  NMT 0.5ppm

Limit of Sodium chloride /IC;

USP<621>;USP<1065>

 NMT 0.2%

Limit of 4-Hydroxybutane-1-sulfonic acid /IC;USP<621>;USP<1065>

  NMT 0.09%

Limit of Bis(4-sulfobutyl) ether disodium /IC;USP<621>;USP<1065>

  NMT 0.05%

Bacterial Endotoxins Test/USP<85>

  ≤10EU/g

Microbial Enumeration Tests/USP<61>

TAMC≤100cfu/g

TYMC≤50 cfu/g

Tests for Specified Microorganisms/USP<62>

Absence of Escherichia Coli/1g

Clarity of Solution(30%,w/v)/visual;see details in the USP Monograph

The solution is clear, and essentially free from particles of foreign matter.

Average Degree of Substitution [DS]/CE;USP<1053>

6.2-6.9


Chemical & Functional Characteristics


  • Anionic β-cyclodextrin derivative
  • Betadex substituted with sulfobutyl ether groups
  • Highly soluble in water
  • Forms stable and reversible inclusion complexes
  • Functions as solubilizer, stabilizer, and release-rate modulator


Key Benefits


  • Significantly enhances aqueous solubility of poorly soluble APIs
  • Improves chemical and physical stability of injectable formulations
  • Reduces renal toxicity compared with traditional solubilizing agents
  • Minimizes hemolysis and injection-site irritation
  • Enables controlled drug release and consistent bioavailability
  • Masks unpleasant odor or taste of APIs when applicable
  • Suitable for repeated parenteral administration

Pharmaceutical Applications


Sulfobutylether Beta Cyclodextrin Sodium Salt is primarily used in injectable and parenteral dosage forms, including:

  • Intravenous (IV) injections
  • Intramuscular (IM) injections
  • Subcutaneous injections
  • Ophthalmic injectable and solution formulations
  • Specialized parenteral drug delivery systems

Main therapeutic areas: antifungal, antiviral, oncology, cardiovascular medicines.


Marketed Drug Applications


SBECD has been successfully applied in several commercially marketed injectable products, demonstrating its proven clinical performance:


  • Remdesivir Injection
  • Posaconazole Injection
  • Voriconazole Injection
  • Melphalan Hydrochloride for Injection
  • Ziprasidone Mesylate Injection


Product Specifications


  • Appearance: White to off-white amorphous powder
  • Grade: Injectable pharmaceutical excipient
  • Standards: EP / USP
  • CAS No.: 182410-00-0
  • Solubility in water: ≥ 100 g/100 mL (25°C)
  • Endotoxin: Controlled for parenteral use
  • Impurities: Strictly controlled
  • Degree of substitution: Consistent batch-to-batch
  • Shelf life: 36 months under recommended storage conditions

A Certificate of Analysis (COA) is provided with each batch.

Manufacturing & Supply Capability


Xi’an Deli Biochemical Industry Co., Ltd. is an established manufacturer of injectable-grade SBECD with reliable commercial-scale supply capabilities.


  • Annual production capacity: over 200 metric tons
  • Typical batch size: approximately 2.5 metric tons
  • Controlled clean manufacturing environment
  • ISO 9001 certified quality management system
  • Comprehensive analytical control of endotoxins, impurities, and substitution degree


Quality Assurance


  • Compliance with EP and USP requirements
  • Strict endotoxin and impurity control
  • Excellent batch-to-batch consistency
  • Full traceability and technical documentation
  • COA and technical data available upon request


Storage & Handling


  • Store in a cool, dry place in tightly sealed containers
  • Protect from moisture
  • Non-hazardous for transport under normal conditions


Why Choose Xi’an Deli Biochemical


  • Over 26 years of experience in cyclodextrin manufacturing
  • Dedicated production lines for injectable pharmaceutical excipients
  • Proven long-term supply to global pharmaceutical customers
  • Strong technical support for formulation development
  • Reliable quality and scalable production capacity

Contact Us


For samples, technical data, or quotations for Sulfobutylether Beta Cyclodextrin Sodium Salt (CAS 182410-00-0), please contact Xi’an Deli Biochemical Industry Co., Ltd.



Hot Tags: Sulfobutylether Beta Cyclodextrin Sodium Salt CAS No. 182410-00-0, Manufacturers, Suppliers, China, Factory, bulk, Free Sample, Made in China, In Stock, Wholesale, Buy

Related Category

Send Inquiry

Please Feel free to give your inquiry in the form below. We will reply you in 24 hours.
icon
X
Privacy Policy
Reject Accept